Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Jun;17(6):679-85.
doi: 10.1111/j.1365-2125.1984.tb02403.x.

The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol

M S Lennard, P R Jackson, S Freestone, G T Tucker, L E Ramsay, H F Woods

The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol

M S Lennard et al. Br J Clin Pharmacol. 1984 Jun.

Abstract

The pharmacokinetics and pharmacodynamics of propranolol (80 mg by mouth) were studied in seven extensive and four poor metabolisers of debrisoquine. Evidence for impairment of the 4'-hydroxylation of propranolol was found in poor metabolisers. However, no significant difference was detected in the oral clearance of unchanged drug between the two groups of debrisoquine oxidation phenotypes. Poor metabolisers of debrisoquine did not experience more intense or more prolonged beta-adrenoceptor blockade than extensive metabolisers of debrisoquine.

PubMed Disclaimer

References

    1. Clin Pharmacol Ther. 1970 Jan-Feb;11(1):112-20 - PubMed
    1. Br J Pharmacol. 1971 Sep;43(1):222-35 - PubMed
    1. Clin Pharmacol Ther. 1972 Mar-Apr;13(2):181-5 - PubMed
    1. J Pharmacokinet Biopharm. 1977 Dec;5(6):625-53 - PubMed
    1. Clin Pharmacol Ther. 1980 Jun;27(6):744-55 - PubMed

LinkOut - more resources